The device was not returned for analysis.The lot history record (lhr) and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other incidents from this lot.Factors contributing to a stent fracture/break include, but are not limited to, manufacturing, interaction with accessory devices, over expansion of the stent, inadvertent mishandling, or anatomical characteristics.The investigation was unable to determine a conclusive cause for the reported stent break.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2023, the 4x48mm xience skypoint stent was implanted to treat a fractured stent that had been implanted in a previous procedure.On (b)(6) 2023, the xience skypoint stent was noted to also have become fractured.No treatment was performed.There was no adverse patient sequela.No additional information was provided.
|